Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.

Alzate D, Sánchez AY, Pacheco Y, Isaza Ruget M, Sánchez R, Castillo C, Parra-López CA.

Open source

DOI
10.1371/journal.pone.0356762
Published
2026-08-24
Container
PLoS One
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0356762,
  title = {Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.},
  author = {Alzate D and  Sánchez AY and  Pacheco Y and  Isaza Ruget M and  Sánchez R and  Castillo C and  Parra-López CA.},
  year = {2026},
  journal = {PLoS One},
  doi = {10.1371/journal.pone.0356762},
  url = {https://doi.org/10.1371/journal.pone.0356762}
}

RIS

TY  - JOUR
TI  - Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.
AU  - Alzate D
AU  -  Sánchez AY
AU  -  Pacheco Y
AU  -  Isaza Ruget M
AU  -  Sánchez R
AU  -  Castillo C
AU  -  Parra-López CA.
PY  - 2026
JO  - PLoS One
DO  - 10.1371/journal.pone.0356762
UR  - https://doi.org/10.1371/journal.pone.0356762
ER  - 

APA

D, A., AY, S., Y, P., M, I. R., R, S., C, C., & CA., P. (2026). Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer.. PLoS One. https://doi.org/10.1371/journal.pone.0356762

Source records